DALLA CHIESA, M.; PASSALACQUA, R.; MICHIARA, ET AL., M. Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon a–2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial. Acta Biomedica Atenei Parmensis, Fidenza, Italy, v. 78, n. 3, p. 204–209, 2007. Disponível em: https://mattioli1885journals.com/index.php/actabiomedica/article/view/1903.. Acesso em: 27 jul. 2024.